Tenet Healthcare Corp
NYSE:THC

Watchlist Manager
Tenet Healthcare Corp Logo
Tenet Healthcare Corp
NYSE:THC
Watchlist
Price: 188.99 USD -0.26% Market Closed
Market Cap: $16.6B

Tenet Healthcare Corp
Investor Relations

In the bustling realm of healthcare, Tenet Healthcare Corporation stands as a dynamic force, intertwining patient care with resilient business strategies. Based in Dallas, Tenet has carved out a significant niche in the healthcare industry by operating an extensive network of facilities across the United States. This sprawling empire includes hospitals, surgical centers, and outpatient facilities, all underpinned by its commitment to quality care. Tenet's operations are driven by a keen understanding of community health needs, offering specialized services through its brands, including the renowned Conifer Health Solutions and United Surgical Partners International (USPI). At its core, Tenet's business model is shaped by the drive to enhance accessibility, efficacy, and efficiency in healthcare delivery, balancing patient needs with sound economic strategies.

Financially, Tenet Healthcare generates revenue through a blend of patient services, surgical operations, and management consulting via its subsidiaries. By aligning its hospital network with the ever-growing demand for outpatient surgery services, particularly through USPI, the company taps into the profitable sphere of ambulatory care. Conifer Health Solutions, on the other hand, provides innovative revenue cycle and value-based care services, fostering sustainable financial health for healthcare providers nationwide. This multifaceted approach allows Tenet to continuously scale its operations while adapting to the evolving landscape of healthcare regulations and consumer expectations. Through strategic acquisitions and partnerships, Tenet ensures its expansion is both sustainable and aligned with emerging healthcare trends, underpinning its robustness in an ever-competitive field.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 28, 2025
AI Summary
Q3 2025

Strong Q3 Results: Tenet Healthcare reported robust third quarter revenue of $5.3 billion with consolidated adjusted EBITDA of $1.1 billion, exceeding expectations for both metrics.

Margin Expansion: Adjusted EBITDA margin rose to 20.8%, up 170 basis points year-over-year, reflecting strong same-store growth and ongoing efficiency improvements.

Guidance Raised: The company increased full-year 2025 adjusted EBITDA guidance to $4.47–$4.57 billion and boosted free cash flow guidance, reflecting confidence in sustained performance.

USPI Performance: The ambulatory segment (USPI) saw 12% adjusted EBITDA growth and 8.3% same-facility revenue growth, with continued momentum in M&A and de novo center openings.

Capital Investment: CapEx guidance for 2025 was raised by $150 million at the midpoint, focusing on high-acuity hospital service lines and continued USPI expansion.

Labor and Inflation: Labor costs and contract labor have been well managed in 2025, with no major inflationary issues anticipated in the near term.

Cash Flow Strength: Free cash flow reached $778 million in Q3 and $2.16 billion year-to-date, up 22% over the prior year.

Key Financials
Net Operating Revenue
$5.3 billion
Adjusted EBITDA
$1.1 billion
Adjusted EBITDA Margin
20.8%
USPI Adjusted EBITDA
$492 million
USPI Adjusted EBITDA Margin
38.6%
USPI Same-Facility Revenue Growth
8.3%
Net Revenue per USPI Case
up 6.1%
USPI Same-Facility Case Volume
up 2.1%
Hospital Segment Adjusted EBITDA
$607 million
Hospital Segment Adjusted EBITDA Margin
15.1%
Same-Hospital Inpatient Adjusted Admissions
up 1.4%
Revenue per Adjusted Hospital Admission
up 5.9%
Consolidated Salary, Wages and Benefits
41.7% of net revenues
Contract Labor Expense as % of SWB
1.9%
Free Cash Flow (Q3)
$778 million
Free Cash Flow (YTD)
$2.16 billion
Free Cash Flow Minus NCI (2025 Guidance)
$1.495–$1.695 billion
Cash on Hand
$2.98 billion
Leverage Ratio
2.3x EBITDA
Shares Repurchased (Q3)
598,000 shares for $93 million
Shares Repurchased (YTD)
7.8 million shares for $1.2 billion
M&A Spend (USPI, YTD)
nearly $300 million
Earnings Call Recording
Other Earnings Calls

Management

Dr. Saumya Sutaria M.D.
Chairman & CEO
No Bio Available
Ms. Paola M. Arbour
Executive VP & Chief Information Officer
No Bio Available
Mr. Thomas W. Arnst
EVP, Chief Administrative Officer, Chief Risk Officer, General Counsel & Corporate Secretary
No Bio Available
Ms. Lisa Y. Foo
Executive Vice President of Commercial Operations
No Bio Available
Mr. Sun K. Park
Executive VP & CFO
No Bio Available
Mr. William McDowell III
Vice President of Investor Relations
No Bio Available
Ms. Jana Durfee
Senior VP & Chief Compliance Officer
No Bio Available
Mr. Michael T. Maloney
Executive Vice President of Corporate Development
No Bio Available
Mr. Clint Hailey
Chief Managed Care Officer & Senior VP
No Bio Available
Ms. Liz Johnson
Chief Applied Clinical Informatics Officer
No Bio Available

Contacts

Address
TEXAS
Dallas
14201 Dallas Parkway
Contacts
+14698932200.0
www.tenethealth.com